Keyword Connections

induced pluripotent stem cells

Journals

10

1 Stem cell research

2 pediatric cardiology

3 faseb journal : official publication of the federation of american societies for experimental biology

4 stem cell research & therapy

5 molecular therapy methods & clinical development

6 intractable & rare diseases research

7 Molecular autism

8 differentiation; research in biological diversity

9 equine veterinary journal

10 bjs open

Research Groups

0

No Research Group Connected

Bibliographies

64

1 Increased Ca signaling in neurons derived from ASD induced pluripotent stem cells.

2 Immune potential of allogeneic equine induced pluripotent stem cells.

3 Non-viral reprogramming and induced pluripotent stem cells for cardiovascular therapy.

4 Recapitulating idiopathic pulmonary fibrosis related alveolar epithelial dysfunction in a human iPSC-derived air-liquid interface model.

5 Association of bacteria in pancreatic fistula fluid with complications after pancreatic surgery.

6 recent progress in the regeneration of spinal cord injuries by induced pluripotent stem cells

7 pluripotent stem cells induced to neural lineages and neural tissues.

8 the model of distributor chain financing based on buy back guarantee contract

9 development of gonadotropin-releasing hormone-secreting neurons from human pluripotent stem cells

10 research on induced pluripotent stem cells and the application in ocular tissues

11 rapid generation of human genetic loss-of-function ipsc lines by simultaneous reprogramming and gene editing

12 the state of play with ipscs and spinal cord injury models

13 advancing stem cell models of alpha-synuclein gene regulation in neurodegenerative disease

14 rapid generation of sub-type, region-specific neurons and neural networks from human pluripotent stem cell-derived neurospheres

15 prospects and challenges of induced pluripotent stem cells in equine health

16 mucosal-associated invariant t cells in regenerative medicine

17 Genotyping, generation and proteomic profiling of the first human autosomal dominant osteopetrosis type II-specific induced pluripotent stem cells.

18 Osteopetrotic induced pluripotent stem cells derived from patients with different disease-associated mutations by non-integrating reprogramming methods.

19 Applying hydrodynamic pressure to efficiently generate induced pluripotent stem cells via reprogramming of centenarian skin fibroblasts.

20 Reference Transcriptome for Deriving Marmoset Induced Pluripotent Stem Cells.

21 Optimization of episomal reprogramming for generation of human induced pluripotent stem cells from fibroblasts.

22 Generation of transgene-free porcine intermediate type induced pluripotent stem cells.

23 Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.

24 Oral Mucosa-Derived Induced Pluripotent Stem Cells from Patients with Ectrodactyly-Ectodermal Dysplasia-Clefting Syndrome.

25 Optimizing the method for generation of integration-free induced pluripotent stem cells from human peripheral blood.

26 Generation of urine-derived induced pluripotent stem cells from a patient with phenylketonuria.

27 Seamless Genetic Conversion of SMN2 to SMN1 via CRISPR/Cpf1 and Single-Stranded Oligodeoxynucleotides in Spinal Muscular Atrophy Patient-Specific Induced Pluripotent Stem Cells.

28 Comparative characterization of human induced pluripotent stem cells (hiPSC) derived from patients with schizophrenia and autism

29 Chimeric G-CSF Receptor-Mediated STAT3 Activation Contributes to Efficient induction of Cardiomyocytes from Mouse Induced Pluripotent Stem Cells.

30 Recent advances of induced pluripotent stem cells application in neurodegenerative diseases

31 Three-dimensional decellularized amnion membrane scaffold promotes the efficiency of male germ cells generation from human induced pluripotent stem cells.

32 Strategies for the expansion of human induced pluripotent stem cells as aggregates in single-use Vertical-Wheel™ bioreactors.

33 Effect of different feeding schedules on the survival and neural differentiation of human embryonic and induced pluripotent stem cells

34 Pathogenesis of fulminant type 1 diabetes: Genes, viruses and the immune mechanism, and usefulness of patient-derived induced pluripotent stem cells for future research

35 Efficient Production of Hepatocyte-like Cells from Human-induced Pluripotent Stem Cells by Optimizing Growth Factors

36 Improved methods for the differentiation of hypothalamic vasopressin neurons using mouse induced pluripotent stem cells.

37 Micro-Engineered Models of Development Using Induced Pluripotent Stem Cells.

38 A hybrid microfluidic system for regulation of neural differentiation in induced pluripotent stem cells.

39 Extracellular Vesicles Derived from Induced Pluripotent Stem Cells Promote Renoprotection in Acute Kidney Injury Model.

40 In vitro modelling of alveolar repair at the air-liquid interface using alveolar epithelial cells derived from human induced pluripotent stem cells

41 Therapeutic efficacy of catalpol against apoptosis in cardiomyocytes derived from human induced pluripotent stem cells

42 Author Correction: Role of astroglia in Down’s syndrome revealed by patient-derived human-induced pluripotent stem cells (Nature Communications, (2014), 5, 1, (4430), 10.1038/ncomms5430)

43 melanin transfer in human 3d skin equivalents generated exclusively from induced pluripotent stem cells.

44 differentiation of induced pluripotent stem cells into male germ cells in vitro through embryoid body formation and retinoic acid or testosterone induction

45 generation of induced pluripotent stem cells (aro-ipsc1-11) from a patient with autosomal recessive osteopetrosis harboring the c.212 + 1g > t mutation in snx10 gene

46 efficient generation of myelinating oligodendrocytes from primary progressive multiple sclerosis patients by induced pluripotent stem cells

47 factor-reduced human induced pluripotent stem cells efficiently differentiate into neurons independent of the number of reprogramming factors

48 establishment of mui009 – a human induced pluripotent stem cells from a 32 year old male with homozygous β°-thalassemia coinherited with heterozygous α-thalassemia 2

49 rock inhibitor primes human induced pluripotent stem cells to selectively differentiate towards mesendodermal lineage via epithelial-mesenchymal transition-like modulation

50 putative epimutagens in maternal peripheral and cord blood samples identified using human induced pluripotent stem cells

51 inflammatory responses and barrier function of endothelial cells derived from human induced pluripotent stem cells

52 targeted correction and restored function of the cftr gene in cystic fibrosis induced pluripotent stem cells

53 scalable generation of universal platelets from human induced pluripotent stem cells

54 the promise and challenge of induced pluripotent stem cells for cardiovascular applications

55 a panel of cpg methylation sites distinguishes human embryonic stem cells and induced pluripotent stem cells

56 cgmp-manufactured human induced pluripotent stem cells are available for pre-clinical and clinical applications

57 mesenchymal and induced pluripotent stem cells: general insights and clinical perspectives

58 comparison of 2d and 3d neural induction methods for the generation of neural progenitor cells from human induced pluripotent stem cells

59 reprogramming human endometrial fibroblast into induced pluripotent stem cells

60 ctip-specific roles during cell reprogramming have long-term consequences in the survival and fitness of induced pluripotent stem cells

61 vaccination with human induced pluripotent stem cells creates an antigen-specific immune response against hiv-1 gp160

62 generation of induced pluripotent stem cells from a patient with parkinson's disease carrying lrrk2 p.i2012t mutation

63 generation of induced pluripotent stem cells (ipscs) from a hereditary spastic paraplegia patient carrying a homozygous y275x mutation in cyp7b1 (spg5)

64 comparative study of human embryonic stem cells (hesc) and human induced pluripotent stem cells (hipsc) as a treatment for retinal dystrophies